What is the recommended comprehensive assessment and management for a diabetic foot ulcer, including off‑loading, wound care, infection control, glycemic optimization, vascular evaluation, and follow‑up?

Diabetic Foot Management

Immediate Core Interventions (Standard of Care)

Every diabetic foot ulcer requires sharp debridement with a scalpel at every visit to remove all necrotic tissue, slough, and surrounding callus—this is the only debridement method with strong evidence support. 1

Sharp Debridement Protocol

• Perform scalpel debridement at each clinical encounter, with frequency determined by wound appearance rather than a fixed schedule. 1, 2
• Remove all nonviable tissue, slough, and periwound callus aggressively until healthy bleeding tissue is reached. 3, 1
• Do not use enzymatic debridement, ultrasonic debridement, honey, or herbal products—these lack evidence and delay appropriate care. 1, 2

Off-Loading Strategy

• Apply a non-removable knee-high device (total-contact cast or irremovable walker) as first-line therapy for all plantar forefoot and midfoot ulcers. 1, 4
• Non-removable devices are critical because patients remove conventional boots at home, undermining healing. 1
• If contraindicated or not tolerated, use a removable knee-high or ankle-high device with intensive adherence counseling. 1
• When no device is available, apply felted foam combined with appropriate footwear as third-line option. 1
• Never rely on conventional therapeutic footwear alone for active ulcer healing. 1

Wound Dressing

• Clean the wound with water or saline only—avoid antiseptic solutions. 1, 4
• Apply simple moisture-absorbing dressings (plain gauze or non-adherent dressings) that maintain moist environment and control exudate. 1, 4
• Do not use topical antiseptic or antimicrobial dressings (including silver, iodine, Betadine)—strong evidence shows no benefit and potential harm from maceration. 1, 4
• Do not use collagen, alginate, honey, bee products, topical phenytoin, or herbal dressings—9 of 12 trials showed no benefit. 1

---

Vascular Assessment (Critical Early Step)

Assess arterial perfusion immediately in every diabetic foot ulcer by palpating pedal pulses and measuring ankle-brachial index (ABI). 1

Perfusion Evaluation Protocol

• If one or more pedal pulses are absent or ABI < 0.9, obtain toe pressure or transcutaneous oxygen pressure (TcPO₂). 1
• ABI may be falsely elevated in calcified vessels; toe pressure and TcPO₂ are more accurate. 1
• Healing is severely compromised when ABI < 0.6, toe pressure < 50 mmHg, or TcPO₂ < 30 mmHg—revascularization (surgical bypass or endovascular therapy) should be considered. 1
• For heel ulcers specifically, urgent revascularization is indicated when toe pressure < 30 mmHg, TcPO₂ < 25 mmHg, ankle pressure < 50 mmHg, or ABI < 0.5. 1
• If no clinical improvement occurs within 6 weeks despite optimal management, consider revascularization regardless of bedside perfusion test results. 1

---

Infection Management

Initiate antibiotics only when clinical signs of infection are present—do not treat uninfected wounds with antimicrobials. 1

Infection Assessment

• Look for purulence, erythema extending > 2 cm from wound edge, warmth, tenderness, induration, fever, or leukocytosis. 1
• Probe the wound to assess for exposed bone, tendon, or joint involvement. 1
• Obtain tissue specimens from the debrided wound base via curettage or biopsy—avoid swabbing undebrided ulcers. 1

Antibiotic Selection

• For superficial skin infection: Cleanse, debride, and start empiric oral antibiotics targeting Staphylococcus aureus and streptococci. 1
• For deep or limb-threatening infection: Urgently assess for surgical drainage, consider revascularization if peripheral arterial disease is present, and begin empiric parenteral broad-spectrum antibiotics covering Gram-positive, Gram-negative, and anaerobic organisms. 1

---

Glycemic and Systemic Optimization

• Target blood glucose < 8 mmol/L (< 140 mg/dL). 1
• Treat edema and malnutrition. 1
• Implement cardiovascular risk reduction: smoking cessation, control hypertension and dyslipidemia, prescribe low-dose aspirin or clopidogrel. 1

---

Charcot Neuroarthropathy Recognition

Any patient with neuropathy presenting with a warm, swollen, red foot with or without trauma and without open ulceration requires immediate evaluation for Charcot neuroarthropathy. 3

• Obtain foot and ankle X-rays in all patients with these clinical findings. 3
• Early diagnosis is paramount to prevent deformities and instability leading to ulceration and amputation. 3
• These patients require total non-weight-bearing and urgent referral to a foot care specialist. 3

---

Adjunctive Therapies (Only After Standard Care Optimization)

Consider adjunctive therapies only if the wound shows < 50% area reduction after 2 weeks of optimized standard care (sharp debridement, off-loading, basic dressings, infection control, vascular assessment). 3, 1

Evidence-Based Adjunctive Options

• Sucrose-octasulfate-impregnated dressing for non-infected neuro-ischemic ulcers (conditional recommendation; moderate certainty). 1, 4
• Hyperbaric oxygen therapy for neuro-ischemic or ischemic ulcers refractory to standard care (conditional recommendation; low certainty). 1, 4
• Topical oxygen therapy for ulcers unresponsive to standard care (conditional recommendation; low certainty). 1
• Autologous leucocyte-platelet-fibrin patches where resources exist for regular venepuncture (conditional recommendation; moderate certainty). 1, 4

Therapies to Avoid

• Do not use negative-pressure therapy, growth factors, bioengineered tissue, acellular matrix, or stem cell therapy routinely—robust RCTs are lacking. 3, 2
• Do not use physical-therapy modalities (ultrasound, electrical stimulation, shockwaves) for wound healing. 1, 2

---

Surgical Options for Non-Healing Ulcers

When non-surgical off-loading fails for plantar forefoot ulcers, consider surgical offloading procedures such as Achilles tendon lengthening, metatarsal head resection, joint arthroplasty, or metatarsal osteotomy. 3, 1

• For neuropathic plantar or apex lesser-digit ulcers secondary to flexible toe deformity, perform digital flexor tendon tenotomy. 1
• Surgical reconstruction of complex limb-threatening deformities by experienced diabetic foot surgeons yields high levels of success and limb salvage. 3
• Rule out underlying osteomyelitis as a cause for non-healing ulcer and treat as necessary. 3

---

Follow-Up and Reassessment

• Re-evaluate outpatients in 2–4 days, inpatients daily, and earlier if condition worsens. 1
• If insufficient improvement is observed after 2 weeks, adjust treatment. 4
• Seek urgent care when signs of infection develop, fever occurs, or wound fails to improve after 2–3 days of basic care. 4

---

Prevention and Long-Term Management

• Daily foot inspection by patient or caregiver, especially in those with sensory deficits. 4
• Use moisturizers for dry, scaly skin; avoid self-care of ingrown nails and calluses. 3
• Well-fitted athletic or walking shoes with customized pressure-relieving orthoses for those with increased plantar pressures. 3
• Individuals with deformities (bunions, hammertoes) may require extra-depth shoes; those with Charcot joint disease may require custom-made footwear. 3
• Avoid footbaths, which cause skin maceration and impede healing. 1
• After ulcer healing, prescribe therapeutic footwear with demonstrated plantar pressure-relieving effect to prevent recurrence. 4
• High-risk patients should be monitored every 1–3 months; moderate-risk patients every 3–6 months. 4

---

Common Pitfalls

• Failing to provide adequate off-loading is the most common error. 4
• Overreliance on advanced therapies before optimizing standard care delays healing. 4
• Using antimicrobial dressings when infection is not documented worsens periwound maceration. 2
• Neglecting vascular assessment leads to failed healing despite optimal wound care. 1
• Ignoring recurrence risk after healing—42% recur at 1 year, 65% at 5 years. 5